Participants

Absco Therapeutics
Alexandria
Alloy Therapeutics
Andreessen Horowitz
Aquilo Partners
Arbor Biotechnologies
Arcturus Therapeutics
Arrakis Therapeutics
AstraZeneca
Atlas Venture
Axonis Therapeutics
Banc of California
Blackbird Laboratories
Breakout Ventures
Citizens Private Bank
Concerto Biosciences
Delix Therapeutics
Delphia Therapeutics
DLA Piper
Droplet Biosciences
Eikonizo Therapeutics
Eledon Pharmaceuticals
Entact Bio
Entrada Therapeutics
Evotec

Garuda Therapeutics
General Proximity
GlycoMimetics
Gordian Ventures
GrayBella Capital
Halloran Consulting Group
HC Bioscience
Hevolution
Immunscope
Incubate Coalition
Ipsen
Johnson & Johnson Innovation -
JJDC
KiraGen Bio
Kojin Therapeutics
Kynexis THerapeutics
Lucy Therapeutics
Lumira Ventures
Lyndra Therapeutics
Lytica Therapeutics
MacDougall

Martrisome Bio
Merck
Neptune Bio
NextRNA Therapeutics
Normunity
Nova Nordisk
Novita Pharmaceuticals
Nucleate
Oxford Finance
Pretzel Therapeutics
Rapport Therapeutics
ROME Therapeutics
Sanofi
Sante
Satellite Bio
SLAM BioTherapeutics
SpyBiotech
Two Bear Capital
Vertex Ventures HC
Versatope Therapeutics
Vigil Neuroscience
WilmerHale
Worldwide Clinical Trials